MedTrace Logo

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study

NCT03578796 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2024-10-30

No results posted yet for this study

Summary

This study evaluate use of a translated Norwegian version of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS-N) as an early predictor in car-driving, working and use of advanced life-prolonging therapy.

Conditions

Interventions

DIAGNOSTIC_TEST

ECAS-N

assessing ALS-specific cognitive impairment

DIAGNOSTIC_TEST

MoCA

assessing cognitive impairment

DIAGNOSTIC_TEST

CDR

assessing global cognitive impairment, as well as possible diagnosis- and Level of dementia

OTHER

Questionnaire

Questions related to work situation and car driving

Sponsors & Collaborators

  • Western Norway University of Applied Sciences

    collaborator OTHER

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Tina Taule, PhD · Haukeland University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2022-12-31
Completion
2026-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578796 on ClinicalTrials.gov